| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |